Hem › Major depression › Washington
Kliniska studier för Major depression i Washington
21 studier för Major depression söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 19 aug. 2026 · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 14 aug. 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 15 juni 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 11 maj 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 20 jan. 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 okt. 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 23 jan. 2025 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
Rekryterar
Ålder 18 till 64 · Alla kön · Uppdaterad 19 sep. 2024 · NCT06005194Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.